First Author | Rofe AM | Year | 1996 |
Journal | Biochem J | Volume | 314 ( Pt 3) |
Pages | 793-7 | PubMed ID | 8615771 |
Mgi Jnum | J:32966 | Mgi Id | MGI:80454 |
Doi | 10.1042/bj3140793 | Citation | Rofe AM, et al. (1996) Trace metal, acute phase and metabolic response to endotoxin in metallothionein-null mice. Biochem J 314(Pt 3):793-7 |
abstractText | Accumulation of hepatic zinc via metallothionein (MT) induction during infection/inflammation is postulated to benefit a range of metabolic processes. The metabolic consequences of two doses of endotoxin (LPS) (1 and 5 mg/ kg, intraperitoneally) were examined in normal (MT+/+) and MT-null (MT-/-) mice (all results means +/- S.E.M., n = 6). At 16 h after 1 mg/kg LPS, hypozincaemia was pronounced in the MT+/+ mice (4.4+/-0.2 mu M), concomitant with a 36 % increase in hepatic Zn and a >10-fold increase in hepatic MT. Plasma Zn (16.6+/-0.7 mu M) and total hepatic Zn were unchanged in MT-/- mice, confirming the importance of MT in altering plasma and hepatic Zn during inflammation. Plasma iron was lower in LPS-treated MT-/- mice, whereas plasma copper increased to a similar extent in both groups of mice. Plasma fibrinogen more than doubled, and was similar in both groups of mice, which questions the importance of MT in acute-phase protein synthesis. Blood and liver glucose concentrations were not significantly different between groups before or after LPS, whereas blood and liver lactate concentrations were significantly lower (31%, and 24% respectively) in MT-/- mice after LPS. At 16 h after 5 mg/kg LPS, plasma Zn was decreased even further in MT+/+ mice (2.6+/-0.3 mu M), but remained unchanged in MT-/- mice at concentrations significantly above those in 16 h-fasted MT-/- mice (15.8+/ -0.5 versus 11.3+/-0.3 mu M). Total liver Zn was 17% lower than fasting values in MT-/- mice, in contrast with 32% higher in MTS/+ mice. Synthesis of MT (in MT+/+ mice) and fibrinogen in all mice was not further enhanced by the higher LPS dose. Blood glucose was significantly decreased by 18% in MT+/+ mice and by 38 % in MT-/- mice after 5 mg/ kg LPS. There was a marked 44 % decrease in liver glucose in MT-/- mice; that in MT+/+ mice was unchanged from fasting levels, implying a deficit in hepatic gluconeogenesis in LPS-treated MT-/- mice. In the absence of any indication of major hepatotoxicity, the results of this study indicate that energy production, and not acute- phase protein synthesis, may be most influenced by Zn supply during endotoxaemia, suggesting that MT has a role in maintaining hepatic and blood glucose in this metabolic setting. |